Learn about our comprehensive antibody validation methods to ensure monospecificity.  Antibody Validation>>


Dr. Atul K. Tandon quoted in Pharmaceutical Press’ article on What Techniques Effectively Educate Doctors About New Medications

February 26, 2024 in News

What Techniques Effectively Educate Doctors About New Medications? When it comes to equipping doctors with…

Read More

Ximbio Partnership Helps Expand NeoBiotechnologies’ Hybridoma Collection

January 8, 2024 in News

“I have been working with CRT reagents since 1992, when I started my first company,…

Read More

Dr. Atul K. Tandon of NeoBiotechnologies discusses the NLRP3/caspase1/IL-18 signaling pathway in the treatment of eosinophilic esophagitis (EoE)

January 2, 2024 in News

In a new study  conducted at Tulane University in Louisiana and published in Communications Biology, researchers describe a…

Read More

Overcoming Resistance to Technological Change

December 22, 2023 in News

From training and transparency winning over skeptics to resisting AI to preserve authentic content, twelve…

Read More

We hold Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.